Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02310880 · ClinicalTrials.gov registry record

Efficacy of Enhancing Low Vision Mobility Thru Visual Training in Virtual World

A clinical trial of Low Vision, sponsored by University of Alabama at Birmingham.

Completed
Registry status
35
Enrollment target
1
Study location

NCT02310880 is a study of Low Vision that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 35 participants, below the 417-participant average among 8 other Low Vision trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02310880, a study of Low Vision, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
35 participants
Enrollment target
1
Study location

Study Summary

Low vision patients have difficulty acquiring sufficient visual information in a timely manner for the purpose of performing challenging daily tasks, such as traveling independently and safely through busy streets. The advance of virtual reality techniques has provided a potential platform for training low vision patients to use their remaining vision more efficiently, but the key issue is always whether the patient's visual experiences in a virtual world can be transferred to the real world. The proposed study is designed to provide definite answer to this question.

Conditions Studied

Study Locations (1)

Alabama

  • The Clinical Eye Research Facility - Birmingham

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2010-09
Est. Completion 2015-03

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT02310880

The ClinicalTrials.gov registry entry for NCT02310880 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 417-participant average among 8 other Low Vision trials with a reported enrollment target (92% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Low Vision appearing as the primary indexed condition, and to 0 interventions.

NCT02310880 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT02310880 about?

NCT02310880 is a clinical study titled "Efficacy of Enhancing Low Vision Mobility Thru Visual Training in Virtual World". Low vision patients have difficulty acquiring sufficient visual information in a timely manner for the purpose of performing challenging daily tasks, such as traveling independently and safely through busy streets. The advance of virtual reality techniques has provided a potential platform for train...

What is the current status of trial NCT02310880?

This trial is currently completed. The enrollment target is 35 participants. The study started on 2010-09. Estimated completion is 2015-03.

What conditions does trial NCT02310880 study?

This clinical trial studies the following conditions: Low Vision.

Who is sponsoring clinical trial NCT02310880?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02310880 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Low Vision

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.